{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:38:42Z","timestamp":1793709522415,"version":"4.6.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ijid.2026.109171","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:06:09Z","timestamp":1791356769000},"page":"109171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Beyond oxygen requirement: rethinking patient selection for oral antiviral therapy to inform trial design in the omicron era"],"prefix":"10.1016","volume":"173","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2859-8417","authenticated-orcid":false,"given":"Benjamin","family":"Davido","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Loubet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2026.109171_bib0001","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2026.109171_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103315","article-title":"Impact of COVID-19 on disease-specific mortality, healthcare resource utilization, and disease burden across a population over 1 billion in 31 countries: an interrupted time-series analysis","volume":"85","author":"Choi","year":"2025","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ijid.2026.109171_bib0003","doi-asserted-by":"crossref","first-page":"e632","DOI":"10.1016\/S2666-5247(23)00139-8","article-title":"Viral and antibody dynamics of acute infection with SARS-CoV-2 omicron variant (B.1.1.529): a prospective cohort study from Shenzhen, China","volume":"4","author":"Yang","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.ijid.2026.109171_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1037733","article-title":"Longitudinal observation of viral load in patients infected with omicron variant and its relationship with clinical symptoms","volume":"13","author":"Zhou","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijid.2026.109171_bib0005","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/cid\/ciad582","article-title":"The new normal: delayed peak SARS-CoV-2 viral loads relative to symptom onset and implications for COVID-19 testing programs","volume":"78","author":"Frediani","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2026.109171_bib0006","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1080\/07853890.2022.2133162","article-title":"COVID-19 treatments approved in the European Union and clinical recommendations for the management of non-hospitalized and hospitalized patients","volume":"54","author":"Bellino","year":"2022","journal-title":"Ann Med"},{"key":"10.1016\/j.ijid.2026.109171_bib0007","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaf680","article-title":"2025 clinical practice guideline update by the infectious Diseases Society of America on the Treatment and Management of COVID-19: antiviral treatment for mild to moderate COVID-19 in adults","author":"Shumaker","year":"2026","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2026.109171_bib0008","unstructured":"European Centre for Disease Prevention and Control (ECDC). Acute respiratory infections in the EU\/EEA: epidemiological update and current public health recommendations \u2013 winter 2024\/2025 2024. https:\/\/www.ecdc.europa.eu\/en\/news-events\/acute-respiratory-infections-eueea-epidemiological-update-and-current-public-health-0 (accessed 28 September 2026)."},{"key":"10.1016\/j.ijid.2026.109171_bib0009","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cmi.2021.11.007","article-title":"ESCMID COVID-19 living guidelines: drug treatment and clinical management","volume":"28","author":"Bartoletti","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2026.109171_bib0010","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","article-title":"Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19","volume":"386","author":"Hammond","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2026.109171_bib0011","article-title":"Severity of SARS-CoV-2 omicron XBB subvariants in Singapore","volume":"37","author":"Pung","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.ijid.2026.109171_bib0012","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2024.2313062","article-title":"Associations of nirmatrelvir-ritonavir treatment with death and clinical improvement in hospitalized patients with COVID-19 during the omicron wave in Beijing, China: a multicentre, retrospective cohort study","volume":"56","author":"Han","year":"2024","journal-title":"Ann Med"},{"key":"10.1016\/j.ijid.2026.109171_bib0013","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.2147\/IDR.S445826","article-title":"Nirmatrelvir\u2013ritonavir reduced mortality in hospitalized patients with COVID-19 during the omicron outbreak: real-world evidence from Beijing","volume":"17","author":"Zhang","year":"2024","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.ijid.2026.109171_bib0014","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.70177","article-title":"Early versus delayed usage of paxlovid in severe omicron-infected patients with hypoxemia: a prospective multiple-center cohort study","volume":"7","author":"Wang","year":"2024","journal-title":"Health Sci Rep"},{"key":"10.1016\/j.ijid.2026.109171_bib0015","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1164\/rccm.202308-1438OC","article-title":"SARS-CoV-2 viral replication persists in the human lung for several weeks after symptom onset","volume":"209","author":"Tomasicchio","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijid.2026.109171_bib0016","article-title":"Paxlovid plus glucocorticoids treatment in severe Omicron infected patients with hypoxaemia: a prospective multiple-center cohort study","volume":"20","author":"Wang","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2026.109171_bib0017","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.2147\/IDR.S419373","article-title":"Real-world effectiveness of nirmatrelvir\/ritonavir and dexamethasone among hospitalized patients with COVID-19: a prospective cohort study","volume":"16","author":"Liu","year":"2023","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.ijid.2026.109171_bib0018","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S1473-3099(25)00093-3","article-title":"Molnupiravir or nirmatrelvir\u2013ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"25","author":"Horby","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2026.109171_bib0019","article-title":"Efficacy and safety of paxlovid in severe adult patients with SARS-Cov-2 infection: a multicenter randomized controlled study","volume":"33","author":"Liu","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.ijid.2026.109171_bib0020","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/cid\/ciae202","article-title":"Identifying veterans who benefit from nirmatrelvir-ritonavir: a target trial emulation","volume":"79","author":"Yan","year":"2024","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226008064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226008064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:19:07Z","timestamp":1793708347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226008064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":20,"alternative-id":["S1201971226008064"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.109171","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond oxygen requirement: rethinking patient selection for oral antiviral therapy to inform trial design in the omicron era","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.109171","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"109171"}}